Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MTITSE:9438 -0.82%71 EV-to-EBITDA is 4.05 as of Sep. 22, 2026, which is 59% below its 10-year median of 9.86. GuruFocus rates TSE:9438 with a GF Score™ of 71/100 and a GF Value™ of 円856.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 523 Healthcare Providers & Services companies, MTI ranks better than 91.01% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MTI's enterprise value is 円22,317 Mil.
MTI's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was 円5,516 Mil. Therefore, MTI's EV-to-EBITDA for today is 4.05.
The historical rank and industry rank for MTI's EV-to-EBITDA or its related term are showing as below:
TSE:9438'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -308.24 Med: 9.86 Max: 301.98
Current: 3.63
During the past 13 years, the highest EV-to-EBITDA of MTI was 301.98. The lowest was -308.24. And the median was 9.86.
TSE:9438's EV-to-EBITDA is ranked better than 91.01% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 10.11
vs TSE:9438: 3.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-09-22), MTI's stock price is 円607.00.
MTI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was 円63.405. Therefore, MTI's PE Ratio (TTM) for today is 9.57.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
MTI's share price for today is 円607.00.
MTI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円63.405.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for MTI's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9438 vs VEEV, BTSG, TEM: EV-to-EBITDA Comparison
For the Health Information Services subindustry, MTI's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MTI EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MTI's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where MTI's EV-to-EBITDA falls into.
MTI's current Enterprise Value is 円22,317 Mil.
MTI's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円5,516 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MTI (TSE:9438) has a EV-to-EBITDA of 4.05 as of Sep. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on MTI. This is 59% below median its historical median of 9.86. According to the industry distribution chart, MTI ranks #47 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 9%.
Is MTI's EV-to-EBITDA too high?
MTI's current EV-to-EBITDA of 4.05 is 59% below median its 10-year median of 9.86. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.11. MTI's value of 4.05 is 59.9% below this industry median. Based on the distribution chart, MTI ranks #47 out of 523 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MTI has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MTI's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MTI ranks #47 out of 523 companies for EV-to-EBITDA. This places MTI in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.11. MTI's value of 4.05 is 59.9% below this benchmark. While the company's 10-year median is 9.86 vs. the industry median of 10.11, MTI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.11, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MTI's current EV-to-EBITDA of 4.05 is 59.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on MTI. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MTI's current EV-to-EBITDA is 4.05, which is 59% below median its own 10-year median of 9.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MTI stock overvalued right now?
Based on GuruFocus' analysis, MTI (TSE:9438) is currently considered Modestly Undervalued. The stock's GF Value™ is 円856.25, compared to a current price of 円607.00 — trading 29.1% below its estimated fair value. The current EV-to-EBITDA is 4.05, which is 59% below median its 10-year median of 9.86 and 59.9% below the Healthcare Providers & Services industry median of 10.11. MTI's overall GF Score™ is 71/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For MTI (TSE:9438), the current EV-to-EBITDA is 4.05 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MTI (TSE:9438) Overvalued in 2026?
Based on GuruFocus' analysis, MTI stock appears to be undervalued.
The current stock price of 円607.00 is trading 29.1% below its estimated GF Value™ of 円856.25.
GuruFocus considers MTI to be Modestly Undervalued.
Key valuation signals for TSE:9438:
EV-to-EBITDA: 4.05 (59% below median its 10-year median of 9.86)
GF Value™: 円856.25 vs. price of 円607.00 (29.1% below fair value)
Industry Position: 59.9% below the Healthcare Providers & Services median (#47 of 523)
No single metric tells the full story. See the TSE:9438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MTI Ltd. is a Japanese digital content and platform services company. Its Content segment distributes mobile and online entertainment, including music, video, e-books, comics, and lifestyle applications such as weather, maps, and security services, mainly through subscription and pay-per-download models for consumers. The Healthcare segment provides cloud-based systems and platforms for pharmacies, clinics, and other medical providers, supporting medication management and health data handling. The School DX segment offers digital transformation solutions for schools, childcare facilities, and local governments to improve administrative and operational efficiency. The company also operates other digital businesses. MTI is based in Tokyo and primarily serves the Japanese market, generating revenue from recurring subscriptions, content distribution fees, and software and platform service contracts with healthcare institutions, educational organizations, and public-sector customers.
71GF Score
Get the complete analysis for TSE:9438
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9438 has been successfully added to your 
